Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Han, Xianlin; M. Holtzman, David; W. McKeel, Daniel; Kelley, John; Morris, John C.

doi:10.1046/j.1471-4159.2002.00997.x

Cited by 626Alzheimer's disease research and treatmentsSphingolipid Metabolism and SignalingDementia and Cognitive Impairment Research

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Han, Xianlin, M. Holtzman, David, W. McKeel, Daniel, Kelley, John, Morris, John C.·2002·Journal of Neurochemistry

DOI 10.1046/j.1471-4159.2002.00997.x

Open this paper in CoChat — free account

Abstract

In addition to pathology in the gray matter, there are also abnormalities in the white matter in Alzheimer's disease (AD). Sulfatide species are a class of myelin‐specific sphingolipids and are involved in certain diseases of the central nervous system. To assess whether sulfatide content in gray and white matter in human subjects is associated with both the presence of Alzheimer's disease (AD) pathology as well as the stage of dementia, we analyzed the sulfatide content of brain tissue lipid extracts by electrospray ionization mass spectrometry from 22 subjects whose cognitive status at time of death varied from no dementia to very severe dementia. All subjects with dementia had AD pathology. The results demonstrate that: (i) sulfatides were depleted up to 93% in gray matter and up to 58% in white matter from all examined brain regions from AD subjects with very mild dementia, whereas all other major classes of lipid (except plasmalogen) in these subjects were not altered in comparison to those from age‐matched subjects with no dementia; (ii) there was no apparent deficiency in the biosynthesis of sulfatides in very mild AD subjects as characterized by the examination of galactocerebroside sulfotransferase activities in post‐mortem brain tissues; (iii) the content of ceramides (a class of potential degradation products of sulfatides) was elevated more than three‐fold in white matter and peaked at the stage of very mild dementia. The findings demonstrate that a marked decrease in sulfatides is associated with AD pathology even in subjects with very mild dementia and that these changes may be linked with early events in the pathological process of AD.

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2002.00997.x

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Previous studies have shown that the lipids that were or tended to be decreased in PLCG2 KO mice (cerebrosides, sulfatides and plasmalogens) have been also reported to be decreased early in AD.
“Notably, previous studies have shown that the lipids that were or tended to be decreased in PLCG2 KO mice (cerebrosides, sulfatides and plasmalogens) have been also reported to be decreased early in AD (39–41).”
From Multi-omics analyses reveal novel effects of PLCγ2 deficiency in the mouse brain (2023) · cites this paper as [39]

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751 · see citing works
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882 · see citing works
Self-citation
Functions of Ceramide in Coordinating Cellular Responses to Stress
Hannun, Y. A. (1996) · Science · doi:10.1126/science.274.5294.1855 · Cited by 1,632 · see citing works
A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
Brun, A., & Englund, E. (1986) · Annals of Neurology · doi:10.1002/ana.410190306 · Cited by 1,014 · see citing works
Alzheimer's Disease--Genotypes, Phenotype, and Treatments
Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 871 · see citing works
REGULATION OF CERAMIDE PRODUCTION AND APOPTOSIS
Kolesnick, R., & Krönke, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.643 · Cited by 803 · see citing works
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727 · see citing works
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype
Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657 · see citing works
Self-citation
Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology
Merrill, A. H., Schmelz, E.-M., Dillehay, D. L., Spiegel, S., Shayman, J. A., Schroeder, J. J., Riley, R. T., Voss, K. A., & Wang, E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8029 · Cited by 643 · see citing works
Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability
Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A. R., Suzuki, K., Suzuki, K., & Popko, B. (1996) · Cell · doi:10.1016/s0092-8674(00)80093-8 · Cited by 624 · see citing works
Mitochondrial dysfunction in neurodegenerative diseases
Beal, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00114-5 · Cited by 608 · see citing works
Cerebral amyloid deposition and diffuse plaques in ``normal'' aging: Evidence for presymptomatic and very mild Alzheimer's disease
Morris, J. C., Storandt, M., McKeel, D. W., Rubin, E. H., Price, J. L., Grant, E. A., & Berg, L. (1996) · Neurology · doi:10.1212/wnl.46.3.707 · Cited by 603 · see citing works
Self-citation
Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry
Han, X., Holtzman, D. M., & McKeel, D. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00332.x · Cited by 573 · see citing works
Self-citation
Lipid Rafts Are Enriched in Arachidonic Acid and Plasmenylethanolamine and Their Composition Is Independent of Caveolin-1 Expression: A Quantitative Electrospray Ionization/Mass Spectrometric Analysis
PIKE, L. J., Han, X., Chung, K.-N., & Gross, R. W. (2002) · Biochemistry · doi:10.1021/bi0156557 · Cited by 512 · see citing works
Self-citation
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
Lassmann, H., Bancher, C., Breitschopf, H., Węgiel, J., Bobinski, M., Jellinger, K. A., & Wı́sniewski, H. M. (1995) · Acta Neuropathologica · doi:10.1007/bf00294257 · Cited by 458 · see citing works
Regional Membrane Phospholipid Alterations in Alzheimer's Disease
Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H. S., & Markesbery, W. R. (1998) · Neurochemical Research · doi:10.1023/a:1022457605436 · Cited by 440 · see citing works
Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids.
Han, X., & Gross, R. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10635 · Cited by 436 · see citing works
Self-citation
Quantitative Analysis and Molecular Species Fingerprinting of Triacylglyceride Molecular Species Directly from Lipid Extracts of Biological Samples by Electrospray Ionization Tandem Mass Spectrometry
Han, X., & Gross, R. W. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5178 · Cited by 358 · see citing works
Self-citation
Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis
Bosio, A., Binczek, E., & Stoffel, W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13280 · Cited by 347 · see citing works
Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II)
Svennerholm, L. T., & Gottfries, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031039.x · Cited by 327 · see citing works
The Role of Oxidative Stress in Alzheimer Disease
Markesbery, W. R. (1999) · Archives of Neurology · doi:10.1001/archneur.56.12.1449 · Cited by 307 · see citing works
Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry
Han, X., & Gross, R. W. (1995) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(95)00568-4 · Cited by 290 · see citing works
Self-citation
Chemistry and functional distribution of sulfoglycolipids
Ishizuka, I. (1997) · Progress in Lipid Research · doi:10.1016/s0163-7827(97)00011-8 · Cited by 289 · see citing works
Human Vascular Endothelial Cells Are a Rich and Regulatable Source of Secretory Sphingomyelinase
Marathe, S. V., Schissel, S. L., Yellin, M. J., Beatini, N., Mintzer, R., Williams, K. J., & Tabas, I. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4081 · Cited by 273 · see citing works
Ceramide Interaction with the Respiratory Chain of Heart Mitochondria
Di Paola, M., Cocco, T., & Lorusso, M. (2000) · Biochemistry · doi:10.1021/bi9924415 · Cited by 262 · see citing works
Magnetic resonance spectroscopy in AD
Valenzuela, M., & Sachdev, P. S. (2001) · Neurology · doi:10.1212/wnl.56.5.592 · Cited by 256 · see citing works
Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death
Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., & Shimohama, S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5 · Cited by 246 · see citing works
Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease
Mattson, M. P., Barger, S. W., Furukawa, K., Bruce‐Keller, A. J., Wyss‐Coray, T., Mark, R. J., & Mucke, L. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00014-8 · Cited by 243 · see citing works
Metabolic and functional aspects of sulfogalactolipids
Vos, J. P., Lopes‐Cardozo, M., & Gadella, B. M. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90262-3 · Cited by 224 · see citing works
Inflammation of the brain in Alzheimer's disease: implications for therapy
McGeer, P. L., & McGeer, E. G. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.4.409 · Cited by 218 · see citing works
Neuropathology of white matter changes in Alzheimer’s disease and vascular dementia
Englund, E. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051183 · Cited by 213 · see citing works
Ceramide Signaling Downstream of the p75 Neurotrophin Receptor Mediates the Effects of Nerve Growth Factor on Outgrowth of Cultured Hippocampal Neurons
Brann, A. B., Scott, R., Neuberger, Y., Abulafia, D. P., Boldin, S. A., Fainzilber, M., & Futerman, A. H. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08199.1999 · Cited by 194 · see citing works
Involvement of de NovoCeramide Biosynthesis in Tumor Necrosis Factor-α/Cycloheximide-induced Cerebral Endothelial Cell Death
Xu, J., Yeh, C.-H., Chen, S., He, L., Sensi, S. L., Canzoniero, L. M. T., Choi, D. W., & Hsu, C. Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16521 · Cited by 183 · see citing works
Characterization and Direct Quantitation of Ceramide Molecular Species from Lipid Extracts of Biological Samples by Electrospray Ionization Tandem Mass Spectrometry
Han, X. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5536 · Cited by 179 · see citing works
Self-citation
Aging, Metabolism, and Alzheimer Disease: Review and Hypotheses
Finch, C. E., & Cohen, D. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6339 · Cited by 150 · see citing works
Structural determination of glycosphingolipids as lithiated adducts by electrospray ionization mass spectrometry using low-energy collisional-activated dissociation on a triple stage quadrupole instrument
Hsu, F., & TURK, J. W. (2001) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(00)00194-x · Cited by 146 · see citing works
Neural membrane phospholipids in alzheimer disease
Wells, K., Farooqui, A., Liss, L., & Horrocks, L. (1995) · Neurochemical Research · doi:10.1007/bf00992508 · Cited by 139 · see citing works
Alterations in Individual Molecular Species of Human Platelet Phospholipids during Thrombin Stimulation: Electrospray Ionization Mass Spectrometry-Facilitated Identification of the Boundary Conditions for the Magnitude and Selectivity of Thrombin-Induced Platelet Phospholipid Hydrolysis
Han, X., Gubitosi‐Klug, R., Collins, B. J., & Gross, R. W. (1996) · Biochemistry · doi:10.1021/bi952927v · Cited by 135 · see citing works
Self-citation
Diabetes-induced changes in specific lipid molecular species in rat myocardium
Han, X., Abendschein, D. R., Kelley, J., & Gross, R. W. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520079 · Cited by 127 · see citing works
Self-citation
Cerebellar atrophy in Alzheimer's disease—clinicopathological correlations
Węgiel, J., Wı́sniewski, H. M., Dziewíatkowski, J., Badmajew, E., Tarnawski, M. J., Reisberg, ‌., Mlodzik, B., de Leon, M. J., & Miller, D. C. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01279-7 · Cited by 123 · see citing works
Modulation of cell signalling by ceramides
Gómez‐Muñoz, A. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00201-4 · Cited by 118 · see citing works
Electrospray ionization tandem mass spectrometric analysis of sulfatide.
Hsu, F., Bohrer, A., & TURK, J. W. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00034-4 · Cited by 114 · see citing works
Alzheimer’s Disease and the Cerebellum: A Morphologic Study on Neuronal and Glial Changes
Sjöbeck, M., & Englund, E. M. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051260 · Cited by 105 · see citing works
Cerebrovascular Pathology in Alzheimer's Disease and Leukoaraiosis
Brown, W. R., Moody, D. M., Thore, C. R., & Challa, V. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06348.x · Cited by 102 · see citing works
Association of Dementia Severity With Cortical Gray Matter and Abnormal White Matter Volumes in Dementia of the Alzheimer Type
Stout, J. C., Jernigan, T. L., Archibald, S. L., & Salmon, D. P. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550080056013 · Cited by 101 · see citing works
Galactosphingolipids and axono-glial interaction in myelin of the central nervous system
Bosio, A., Büssow, H., Adam, J., & Stoffel, W. (1998) · Cell and Tissue Research · doi:10.1007/s004410051051 · Cited by 81 · see citing works
Elevation of Ceramide within Distal Neurites Inhibits Neurite Growth in Cultured Rat Sympathetic Neurons
de Chaves, E. I. P., Bussière, M., Vance, D. E., Campenot, R. B., & Vance, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.3028 · Cited by 78 · see citing works
Contribution of neuroimaging in the diagnosis of Alzheimerʼs disease and other dementias
Scheltens, P., & Korf, E. S. C. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200008000-00005 · Cited by 73 · see citing works
Cross-talk between Phosphatidylinositol 3-Kinase and Sphingomyelinase Pathways as a Mechanism for Cell Survival/Death Decisions
Burow, M. E., Weldon, C. B., Collins‐Burow, B. M., Ramsey, N. W., McKee, A. S., Klippel, A., McLachlan, J. A., Clejan, S., & Beckman, B. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9628 · Cited by 63 · see citing works
Monoclonal Antibody to Embryonic CNS Antigen A2B5 Provides Evidence for the Involvement of Membrane Components at Sites of Alzheimer Degeneration and Detects Sulfatides as Well as Gangliosides
Majocha, R. E., Jungalwala, F. B., Rodenrys, A., & Marotta, C. A. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11798.x · Cited by 52 · see citing works
Purification and activation of brain sulfotransferase.
Sundaram, K., & Lev, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35942-8 · Cited by 37 · see citing works
Characterization and developmental expression of a novel sulfotransferase for the biosynthesis of sulfoglucuronyl glycolipids in the nervous system.
Chou, D. K. H., & Jungalwala, F. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54154-5 · Cited by 35 · see citing works
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
Lassmann, H., Bancher, C., Breitschopf, H., Węgiel, J., Bobinski, M., Jellinger, K. A., & Wı́sniewski, H. M. (1994) · Acta Neuropathologica · doi:10.1007/s004010050213 · Cited by 32 · see citing works
Discussion
Mattson, M. P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01114-4 · Cited by 30 · see citing works
Selective silver impregnation of senile plaques: a method useful for computer imaging
Hedreen, J. C., Raskin, L. S., Struble, R. G., & Price, D. L. (1988) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(88)90153-7 · Cited by 18 · see citing works
Modulation of testicular galactolipid sulphotransferase activity by phosphorylation. Stimulation of enzyme activity in vitro by an endogenous kinase
Sakac, D., & Lingwood, C. A. (1989) · Biochemical Journal · doi:10.1042/bj2610423 · Cited by 11 · see citing works

Flagged first, then by citations

Sorted by citations

Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples
Han, X., & Gross, R. W. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20023 · Cited by 1,111 · see citing works
Self-citation
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968 · see citing works
Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics
Han, X., & Gross, R. W. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300004-jlr200 · Cited by 914 · see citing works
Self-citation
Targeted Metabolomics
Roberts, L. D., Souza, A. L., Gerszten, R. E., & Clish, C. B. (2012) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb3002s98 · Cited by 714 · see citing works
Metabolomics: A Global Biochemical Approach to Drug Response and Disease
Kaddurah-Daouk, R. F., Kristal, B. S., & Weinshilboum, R. M. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094715 · Cited by 669 · see citing works
Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease
Chan, R. B., Oliveira, T. G., Cortes, E. P., Honig, L. S., Duff, K. E., Small, S. A., Wenk, M. R., Shui, G., & Di Paolo, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274142 · Cited by 630 · see citing works
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546 · see citing works
Deregulation of sphingolipid metabolism in Alzheimer’s disease
He, X., Huang, Y., Li, B., Gong, C.-X., & Schuchman, E. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.010 · Cited by 516 · see citing works
Lipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485 · see citing works
Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise
Yin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441 · see citing works
Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
Han, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., Welsh-Bohmer, K. A., Doraiswamy, P. M., & Kaddurah-Daouk, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021643 · Cited by 429 · see citing works
Self-citation
Biological aging processes underlying cognitive decline and neurodegenerative disease
Gonzales, M. M., Garbarino, V. R., Pollet, E., Palavicini, J. P., Kellogg, D. L., Kraig, E., & Orr, M. E. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158453 · Cited by 394 · see citing works
Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical Applications
Kornhuber, J., Tripal, P., Reichel, M., Mühle, C., Rhein, C., Muehlbacher, M., Groemer, T. W., & Gulbins, E. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315101 · Cited by 356 · see citing works
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Chew, H., Solomon, V. A., & Fonteh, A. N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00598 · Cited by 353 · see citing works
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics
Shaw, L. M. J., Korecka, M., Clark, C. M., Lee, V. M. ‐., & Trojanowski, J. Q. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2176 · Cited by 340 · see citing works
Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry—What, how and why?
Wang, M., Wang, C., & Han, X. (2016) · Mass Spectrometry Reviews · doi:10.1002/mas.21492 · Cited by 305 · see citing works
Self-citation
Role of sulfatide in normal and pathological cells and tissues
Takahashi, T., & Suzuki, T. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r026682 · Cited by 291 · see citing works
Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases
Kaddurah-Daouk, R. F., & Krishnan, K. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.174 · Cited by 289 · see citing works
Cell-Type- and Brain-Region-Resolved Mouse Brain Lipidome
Fitzner, D., Bader, J. M., Penkert, H., Bergner, C. G., Su, M., Weil, M., Surma, M. A., Mann, M., Klose, C. D., & Simons, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108132 · Cited by 280 · see citing works
The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders
Czubowicz, K., Jęśko, H. M., Wencel, P. L., Lukiw, W. J., & Strosznajder, R. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1448-3 · Cited by 285 · see citing works
Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes
Han, X., & Gross, R. W. (2005) · Expert Review of Proteomics · doi:10.1586/14789450.2.2.253 · Cited by 278 · see citing works
Self-citation
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis
Haughey, N. J., Bandaru, V. V. R., Bae, M. H., & Mattson, M. P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.003 · Cited by 271 · see citing works
Novel advances in shotgun lipidomics for biology and medicine
Wang, M., Wang, C., Han, R. H., & Han, X. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.12.002 · Cited by 269 · see citing works
Self-citation
Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration
Liu, Q., Trotter, J., Zhang, J., Peters, M. M., Cheng, H., Bao, J., Han, X., Weeber, E. J., & Bu, G. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4067-10.2010 · Cited by 268 · see citing works
Self-citation
Ceramide Stabilizes β-Site Amyloid Precursor Protein-cleaving Enzyme 1 and Promotes Amyloid β-Peptide Biogenesis
Puglielli, L., Ellis, B. C., Saunders, A. J., & Kovacs, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300466200 · Cited by 265 · see citing works
Retracted
Ceramide function in the brain: when a slight tilt is enough
Mencarelli, C., & Martínez‐Martínez, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1038-x · Cited by 261 · see citing works
MicroRNA-137/181c Regulates Serine Palmitoyltransferase and In Turn Amyloid β, Novel Targets in Sporadic Alzheimer's Disease
Geekiyanage, H., & Chan, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3883-11.2011 · Cited by 254 · see citing works
Biological markers for therapeutic trials in Alzheimer’s disease
Frank, R., Galasko, D., Hampel, H. J., Hardy, J., de Leon, M. J., Mehta, P. D., Rogers, J., Siemers, E., & Trojanowski, J. Q. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00002-2 · Cited by 252 · see citing works
Applications of Metabolomics in Drug Discovery and Development
Wishart, D. S. (2008) · Drugs in R&D · doi:10.2165/00126839-200809050-00002 · Cited by 246 · see citing works
Ceramides in Alzheimer’s Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and A <b> <i>β</i> </b> Accumulation
Jazvinšćak Jembrek, M., Hof, P. R., & Šimić, G. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/346783 · Cited by 244 · see citing works
Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease?
Katsel, P., Li, C., & Haroutunian, V. H. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9297-x · Cited by 240 · see citing works
Biomarkers of Inflammation, Immunosuppression and Stress Are Revealed by Metabolomic Profiling of Tuberculosis Patients
Weiner, J. M., Parida, S. K., Maertzdorf, J., Black, G. F., Repsilber, D., Telaar, A., Mohney, R. P., Arndt-Sullivan, C., Ganoza, C. A., Fae, K. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040221 · Cited by 237 · see citing works
Ceramide and neurodegeneration: Susceptibility of neurons and oligodendrocytes to cell damage and death
Jana, A., Hogan, E. L., & Pahan, K. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.010 · Cited by 233 · see citing works
Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease
Martins, I. J., Berger, T. R., Sharman, M. J., Verdile, G., Fuller, S. J., & Martins, R. N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06408.x · Cited by 233 · see citing works
The ether lipid-deficient mouse: Tracking down plasmalogen functions
Gorgas, K., Teigler, A., Komljenovic, D., & Just, W. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.038 · Cited by 231 · see citing works
Serum ceramides increase the risk of Alzheimer disease
Mielke, M. M., Bandaru, V. V. R., Haughey, N. J., Xia, J., Fried, L. P., Yaşar, S., Albert, M., Varma, V. R., Harris, G., Schneider, E. B., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318264e380 · Cited by 223 · see citing works
Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers
Košiček, M., & Hecimovic, S. K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011310 · Cited by 213 · see citing works
Analytical strategies in lipidomics and applications in disease biomarker discovery
Hu, C., van der Heijden, R., Wang, M., van der Greef, J., Hankemeier, T., & Xu, G. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.01.038 · Cited by 207 · see citing works
Lipidomics era: Accomplishments and challenges
Khalil, M. B., Hou, W., Zhou, H., Elisma, F., Swayne, L. A., Blanchard, A. P., Yao, Z., Bennett, S. A. L., & Figeys, D. (2010) · Mass Spectrometry Reviews · doi:10.1002/mas.20294 · Cited by 205 · see citing works
Alzheimer’s disease: the lipid connection
Hartmann, T., Kuchenbecker, J., & Grimm, M. O. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04715.x · Cited by 199 · see citing works
Recent advances in the application of metabolomics to Alzheimer's Disease
Trushina, E. V., & Mielke, M. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.014 · Cited by 197 · see citing works
Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis
Satoi, H., Tomimoto, H., Ohtani, R., Kitano, T., Kondo, T., Watanabe, M., Oka, N., Akiguchi, I., Furuya, S., Hirabayashi, Y., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.056 · Cited by 195 · see citing works
The Role and Metabolism of Sulfatide in the Nervous System
Eckhardt, M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8022-3 · Cited by 193 · see citing works
Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease
Su, H., Rustam, Y. H., Masters, C. L., Makalic, E., McLean, C., Hill, A. F., Barnham, K. J., Reid, G. E., & Vella, L. J. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12089 · Cited by 187 · see citing works
The role of myelin damage in Alzheimer’s disease pathology
Papuć, E., & Rejdak, K. (2020) · Archives of Medical Science · doi:10.5114/aoms.2018.76863 · Cited by 188 · see citing works
Serum sphingomyelins and ceramides are early predictors of memory impairment
Mielke, M. M., Bandaru, V. V. R., Haughey, N. J., Rabins, P. V., Lyketsos, C. G., & Carlson, M. C. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.011 · Cited by 188 · see citing works
Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline
Chornenkyy, Y., Wang, W., Wei, A. L., & Nelson, P. T. (2018) · Brain Pathology · doi:10.1111/bpa.12655 · Cited by 184 · see citing works
Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease
Han, X. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772786 · Cited by 183 · see citing works
Self-citation
High resolution mass spectrometry based techniques at the crossroads of metabolic pathways
Junot, C., Fenaille, F., Colsch, B., & Bécher, F. (2013) · Mass Spectrometry Reviews · doi:10.1002/mas.21401 · Cited by 177 · see citing works
Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
Kornhuber, J., Muehlbacher, M., Trapp, S., Pechmann, S., Friedl, A., Reichel, M., Mühle, C., Terfloth, L., Groemer, T. W., Spitzer, G. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023852 · Cited by 175 · see citing works
Lipids in Psychiatric Disorders and Preventive Medicine
Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175 · see citing works
Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss
Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Schech, S., Carrick, R., Carlson, M. C., Mori, S., Miller, M. I., Ceritoglu, C., Brown, T., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.014 · Cited by 170 · see citing works
White matter integrity and vulnerability to Alzheimer’s disease: preliminary findings and future directions
Gold, B. T., Johnson, N. F., Powell, D. K., & Smith, C. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.009 · Cited by 170 · see citing works
“This pattern of DTI-based findings is consistent with data demonstrating that myelin and its components such as cholesterol and myelin proteins are reduced early in the AD process [64, 65] and with a recently proposed theory suggesting that disruption of myelin integrity is an early event in the course of AD [66].”
Result
Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition
Song, S.-K., Kim, J. H., Lin, S.-J., Brendza, R. P., & Holtzman, D. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.003 · Cited by 170 · see citing works
Glycosphingolipid Structural Analysis and Glycosphingolipidomics
Levery, S. B. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)05012-3 · Cited by 167 · see citing works
Lipidomics of Alzheimer's disease: current status
Wood, P. L. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt103 · Cited by 167 · see citing works
Direct tissue analysis of phospholipids in rat brain using MALDI-TOFMS and MALDI-ion mobility-TOFMS
Jackson, S. N., Wang, H.-Y. J., Woods, A. S., Ugarov, M. V., Egan, T. F., & Schultz, J. A. (2004) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2004.10.002 · Cited by 167 · see citing works
Sphingolipids: Critical players in Alzheimer’s disease
van Echten‐Deckert, G., & Walter, J. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.07.001 · Cited by 172 · see citing works
White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease
Klosinski, L. P., Yao, J., Yin, F., Fonteh, A. N., Harrington, M. G., Christensen, T. A., Trushina, E. V., & Brinton, R. D. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.002 · Cited by 164 · see citing works
Novel Biomarkers for Predicting Preeclampsia
Carty, D., Delles, C., & Dominiczak, A. F. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.07.002 · Cited by 160 · see citing works
More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration
Lane-Donovan, C., Philips, G. T., & Herz, J. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.005 · Cited by 158 · see citing works
Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Couttas, T. A., Kain, N., Daniels, B., Lim, X. Y., Shepherd, C., Kril, J., Pickford, R., Li, H., Garner, B., & Don, A. S. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-9 · Cited by 161 · see citing works
Altered brain white matter integrity in healthy carriers of the APOE ε4 allele
Persson, J., Lind, J., Larsson, A., Ingvar, M., Cruts, M., Broeckhoven, C. V., Adolfsson, R., Nilsson, L. G., & Nyberg, L. H. (2006) · Neurology · doi:10.1212/01.wnl.0000204180.25361.48 · Cited by 161 · see citing works
LC/MS lipid profiling from human serum: a new method for global lipid extraction
Pellegrino, R. M., Veroli, A. D., Valeri, A., Goracci, L., & Cruciani, G. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8255-0 · Cited by 159 · see citing works
Oxidative Stress and Cell Membranes in the Pathogenesis of Alzheimer's Disease
Axelsen, P. H., Komatsu, H., & Murray, I. V. J. (2011) · Physiology · doi:10.1152/physiol.00024.2010 · Cited by 158 · see citing works
Plasma Sphingomyelins are Associated with Cognitive Progression in Alzheimer's Disease
Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Weinberg, D. D., Darby, E. J., Zaidi, N., Pavlik, V., Doody, R. S., & Lyketsos, C. G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110405 · Cited by 158 · see citing works
Blood–brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration
Bartels, A. L., Kortekaas, R., Bart, J., Willemsen, A. T. M., de Klerk, O. L., de Vries, J. J., van Oostrom, J. C. H., & Leenders, K. L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.002 · Cited by 158 · see citing works
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease
Huynh, K., Lim, W. L. F., Giles, C., Jayawardana, K. S., Salim, A., Mellett, N. A., Smith, A. A. T., Olshansky, G., Drew, B. G., Chatterjee, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19473-7 · Cited by 154 · see citing works
Self-citation
Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease
Han, X. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.01.010 · Cited by 154 · see citing works
Self-citation
Diffusion Tensor Imaging of Frontal White Matter Microstructure in Early Alzheimer’s Disease: A Preliminary Study
Choi, S. J., Lim, K. O., Monteiro, I. M., & Reisberg, ‌. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704271763 · Cited by 153 · see citing works
Modifications of Glycans: Biological Significance and Therapeutic Opportunities
Muthana, S. M., Campbell, C. T., & Gildersleeve, J. C. (2011) · ACS Chemical Biology · doi:10.1021/cb2004466 · Cited by 151 · see citing works
ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain
Bandaru, V. V. R., Troncoso, J. C., Wheeler, D., Pletniková, O., Wang, J., Conant, K., & Haughey, N. J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.024 · Cited by 147 · see citing works
A TrkA-to-p75NTR molecular switch activates amyloid β-peptide generation during aging
Costantini, C., Weindruch, R. H., Valle, G. D., & Puglielli, L. (2005) · Biochemical Journal · doi:10.1042/bj20050700 · Cited by 148 · see citing works
Activation of the <scp>NLRP</scp>3 inflammasome in microglia: the role of ceramide
Scheiblich, H., Schlütter, A., Golenbock, D. T., Latz, E., Martinez‐Martinez, P., & Heneka, M. T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14225 · Cited by 147 · see citing works
Alzheimer's Disease Pathogenesis
Harman, D. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.065 · Cited by 143 · see citing works
The neuropathological profile of mild cognitive impairment (MCI): a systematic review
Stephan, B. C. M., Hunter, S., Harris, D., Llewellyn, D. J., Siervo, M., Matthews, F. E., & Brayne, C. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.147 · Cited by 139 · see citing works
Applications of mass spectrometry to metabolomics and metabonomics: Detection of biomarkers of aging and of age‐related diseases
Mishur, R. J., & Rea, S. L. (2011) · Mass Spectrometry Reviews · doi:10.1002/mas.20338 · Cited by 142 · see citing works
Alterations of the Sphingolipid Pathway in Alzheimer’s Disease: New Biomarkers and Treatment Targets?
Mielke, M. M., & Lyketsos, C. G. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8121-y · Cited by 141 · see citing works
Sub-regional hippocampal injury is associated with fornix degeneration in Alzheimer’s disease.
Lee, D. Y., Fletcher, E., Carmichael, O. T., Singh, B., Mungas, D., Reed, B., Martinez, O., Buonocore, M. H., Persianinova, M., & DeCarli, C. (2012) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2012.00001 · Cited by 137 · see citing works
Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease
Ceccom, J., Loukh, N., Lauwers‐Cancès, V., Touriol, C., Nicaise, Y., Gentil, C., Uro‐Coste, E., Pitson, S. M., Maurage, C., Duyckaerts, C. J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-12 · Cited by 136 · see citing works
Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods
van Kruining, D., Luo, Q., van Echten‐Deckert, G., Mielke, M. M., Bowman, A. P., Ellis, S. R., Oliveira, T. G., & Martínez‐Martínez, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.009 · Cited by 135 · see citing works
Sulfatide, A Major Lipid Component of Myelin Sheath, Activates Inflammatory Responses As an Endogenous Stimulator in Brain-Resident Immune Cells
Jeon, S., Yoon, H. J., Park, S., Kim, I.-H., & Park, E. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.8077 · Cited by 134 · see citing works
Lipid Integration in Neurodegeneration: An Overview of Alzheimer’s Disease
Yadav, R. S., & Tiwari, N. K. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8661-5 · Cited by 134 · see citing works
A matter of fat: An introduction to lipidomic profiling methods
Roberts, L. D., McCombie, G., Titman, C. M., & Griffin, J. L. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.04.002 · Cited by 134 · see citing works
Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism
Akyol, S., Ugur, Z., Yılmaz, A., Ustun, I., Gorti, S. K. K., Oh, K., McGuinness, B., Passmore, P., Kehoe, P. G., Maddens, M. E., et al. (2021) · Cells · doi:10.3390/cells10102591 · Cited by 134 · see citing works
Ceramide in Stress Response
Nikolova‐Karakashian, M., & Rozenova, K. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_6 · Cited by 134 · see citing works
Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer’s disease subjects
Wood, P. L., Barnette, B. L., Kaye, J. A., Quinn, J. F., & Woltjer, R. L. (2015) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.18 · Cited by 129 · see citing works
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Sanchez-Varo, R. M., Mejias‐Ortega, M., Fernandez-Valenzuela, J. J., Nuñez‐Diaz, C., Cáceres-Palomo, L., Vegas‐Gomez, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., García‐León, J. A., Moreno‐González, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 130 · see citing works
Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer’s disease-like neuroinflammation and cognitive impairment
Qiu, S., Palavicini, J. P., Wang, J., Gonzalez, N. S., He, S., Dustin, E., Zou, C., Ding, L., Bhattacharjee, A., Skike, C. E. V., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00488-7 · Cited by 126 · see citing works
Self-citation
Involvement of astroglial ceramide in palmitic acid‐induced Alzheimer‐like changes in primary neurons
Patil, S. P., Melrose, J., & Chan, C. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05797.x · Cited by 126 · see citing works
Novel Role for Apolipoprotein E in the Central Nervous System
Han, X., Cheng, H., Fryer, J. D., Fagan, A. M., & Holtzman, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212340200 · Cited by 126 · see citing works
Self-citation
In situ structural characterization of glycerophospholipids and sulfatides in brain tissue using MALDI-MS/MS
Jackson, S. N., Wang, H. Y. J., & Woods, A. S. (2006) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2006.08.015 · Cited by 126 · see citing works
Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry
Li, N., Liu, W., Li, W., Li, S., Chen, X.-H., Bi, K., & He, P. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.04.072 · Cited by 125 · see citing works
Characterization and direct quantitation of cerebroside molecular species from lipid extracts by shotgun lipidomics
Han, X., & Cheng, H. (2004) · Journal of Lipid Research · doi:10.1194/jlr.d400022-jlr200 · Cited by 125 · see citing works
Self-citation
Brain tissue lipidomics: Direct probing using matrix-assisted laser desorption/ionization mass spectrometry
Woods, A. S., & Jackson, S. N. (2006) · The AAPS Journal · doi:10.1007/bf02854910 · Cited by 124 · see citing works
Multi-Omics Analysis of Microglial Extracellular Vesicles From Human Alzheimer’s Disease Brain Tissue Reveals Disease-Associated Signatures
Cohn, W., Melnik, M., Huang, C., Teter, B., Chandra, S., Zhu, C., McIntire, L. B., John, V., Gylys, K. H., & Bilousova, T. V. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.766082 · Cited by 120 · see citing works
Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide
Farooqui, A., Horrocks, L., & Farooqui, T. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21268 · Cited by 121 · see citing works
Sphingolipid metabolites in neural signalling and function
Colombaioni, L., & Garcia‐Gil, M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.014 · Cited by 119 · see citing works
Liquid ionic matrixes for MALDI mass spectrometry imaging of lipids
Mériaux, C., Franck, J., Wisztorski, M., Salzet, M., & Fournier, I. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.02.010 · Cited by 117 · see citing works
Novel Trimodal MALDI Imaging Mass Spectrometry (IMS3) at 10 μm Reveals Spatial Lipid and Peptide Correlates Implicated in Aβ Plaque Pathology in Alzheimer’s Disease
Kaya, I., Brinet, D., Michno, W., Başkurt, M., Zetterberg, H., Blenow, K., & Hanrieder, J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00314 · Cited by 116 · see citing works

Specific changes of sulfatide levels in individuals with pre‐clinical Alzheimer's disease: an early event in disease pathogenesis
Cheng, H., Wang, M., Li, J., Cairns, N. J., & Han, X. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12368 · Cited by 103 · see citing works
Self-citation
Abstract 1451 Alzheimer's disease is likely a lipid-disorder complication: An example of functional lipidomics research
Han, X. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.106436
Self-citation
Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.
Cheng, H., Xu, J., McKeel, D. W., & Han, X. (2003) · PubMed · Cited by 90 · see citing works
Self-citation
Membrane Components Separate Early-Onset Alzheimer’s Disease From Senile Dementia of the Alzheimer Type
Gottfries, C., Karlsson, I., & Svennerholm, L. (1996) · International Psychogeriatrics · doi:10.1017/s1041610296002736 · Cited by 85 · see citing works
The impact of sulfatide loss on the progress of Alzheimer's disease
Finkielstein, C. V., & Capelluto, D. G. S. (2023) · Clinical and Translational Discovery · doi:10.1002/ctd2.236 · Cited by 2 · see citing works

Authors: Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C.
Affiliations: Washington University in St. Louis (US)
Corresponding author: Han, Xianlin
ORCID: Han, Xianlin
Morris, John C.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 2002-08
Volume: 82
Issue: 4
Pages: 809-818
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1046/j.1471-4159.2002.00997.x
OpenAlex: W1594975246
Cited by: 626
References: 56
Citations by year: 2026: 24 · 2025: 26 · 2024: 29 · 2023: 32 · 2022: 32 · 2021: 29 · 2020: 32 · 2019: 22 · 2018: 29 · 2017: 33 · 2016: 34 · 2015: 24 · 2014: 33 · 2013: 33 · 2012: 36
FWCI: 7.61
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 6 d)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p41rr000954-34)
National Institute on Aging (P 50 AG05681, P50AG005681, P01 AG0 3991, P01AG003991)
National Center for Research Resources (P41RR00954-240043)
Topics: Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, sulfatide, ceramide, white matter, gray matter, brain lipid composition, pathogenesis
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain, Brain Chemistry, Ceramides, Dementia, Galactosylceramides, Humans, Neuropsychological Tests, Severity of Illness Index, Sphingomyelins, Sulfoglycosphingolipids, Sulfotransferases, Disease Progression, Spectrometry, Mass, Electrospray Ionization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks